Edition:
United Kingdom

Cocrystal Pharma Inc (COCP.OQ)

COCP.OQ on NASDAQ Stock Exchange Capital Market

2.80USD
19 Oct 2018
Change (% chg)

$-0.08 (-2.78%)
Prev Close
$2.88
Open
$2.85
Day's High
$2.85
Day's Low
$2.80
Volume
773
Avg. Vol
15,629
52-wk High
$6.43
52-wk Low
$1.61

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.048
Mar '18 0.00 -0.064
FY 2017 Dec '17 0.00 0.212
Sep '17 0.00 -0.093
Jun '17 0.00 -0.041
Mar '17 0.00 -0.107
FY 2016 Dec '16 0.00 -2.762
Sep '16 0.00 -0.080
Jun '16 0.00 -0.137
Mar '16 0.00 -0.173
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Earnings (per share)
Quarter Ending Dec-18 1 -0.08 -0.08 -0.08 --
Quarter Ending Mar-19 1 -0.11 -0.11 -0.11 --
Year Ending Dec-18 1 -0.28 -0.28 -0.28 --
Year Ending Dec-19 1 -0.45 -0.45 -0.45 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.91 33.65
P/E High - Last 5 Yrs. -- 40.50 45.13
P/E Low - Last 5 Yrs. -- 23.27 23.75
Beta 1.93 0.89 0.88
Price to Sales (TTM) -- 3.93 5.82
Price to Book (MRQ) 1.74 4.77 4.89
Price to Tangible Book (MRQ) -- 5.60 6.51
Price to Cash Flow (TTM) -- 22.55 22.93
% Owned Institutions 0.01 1.13 2.13

Dividends

  Company industry sector
Dividend Yield -- 1.58 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.41 5.40
Payout Ratio(TTM) -- 46.17 43.86

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.22 8.09
Sales (TTM) vs TTM 1 Yr. Ago -100.00 4.64 5.80
Sales - 5 Yr. Growth Rate -- 9.68 9.87
EPS (MRQ) vs Qtr. 1 Yr. Ago 69.87 19.95 23.78
EPS (TTM) vs TTM 1 Yr. Ago -80.95 -- --
EPS - 5 Yr. Growth Rate -- 9.95 10.93
Capital Spending - 5 Yr. Growth Rate -38.41 15.08 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.25
Current Ratio (MRQ) 2.74 2.97 3.05
LT Debt to Equity (MRQ) 0.00 9.95 12.75
Total Debt to Equity (MRQ) 0.00 13.98 17.17
Interest Coverage (TTM) -- 41.52 37.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.19 54.87
Gross Margin - 5 Yr. Avg. -- 52.28 52.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -196,820.59 18.46 11.02
Operating Margin (TTM) -- 14.31 4.30
Operating Margin - 5 Yr. Avg. -201,893.70 14.34 6.36
Pre-Tax Margin (TTM) -- 14.86 5.35
Pre-Tax Margin - 5 Yr. Avg. -208,399.09 14.79 6.80
Net Profit Margin (TTM) -- 11.08 1.62
Net Profit Margin - 5 Yr. Avg. -157,026.70 11.06 3.04
Effective Tax Rate (TTM) -- 23.36 23.24
Effective Tax Rate - 5 Yr. Avg. -- 23.59 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 909,900,986 808,425,748
Net Income/Employee (TTM) -3,954,722 107,071,320 95,083,073
Receivable Turnover (TTM) -- 5.62 5.77
Inventory Turnover (TTM) -- 2.61 3.63
Asset Turnover (TTM) 0.00 0.94 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -41.33 11.36 10.91
Return on Assets - 5 Yr. Avg. -24.46 12.60 12.01
Return on Investment (TTM) -41.96 14.75 14.28
Return on Investment - 5 Yr. Avg. -25.93 16.43 15.61
Return on Equity (TTM) -52.95 16.25 16.00
Return on Equity - 5 Yr. Avg. -64.56 17.49 16.87
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % -33.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cocrystal Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.92%
# of Holders: 29
Total Shares Held: 2,370,133
3 Mo. Net Change: 39,726
# New Positions: 2
# Closed Positions: 1
# Increased Positions: 3
# Reduced Positions: 2
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.